CVS vs SOLV: fair value comparison
CVS Health Corporation and Solventum Corporation · Updated 2026-09-07
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, SOLV currently sits closer to the top of our discount ranking.
| CVS | SOLV | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $96.74 | $91.69 |
| 12-month range | $72.49–$105.37 | $64.35–$90.95 |
| Sector rank | #92 of 113 Healthcare | #87 of 113 Healthcare |
| Quality grade | F | F |
| Leverage | Moderate | High |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: CVS fair value analysis · SOLV fair value analysis